Hwail Pharmaceutical Co.Ltd (061250) — Working Capital to Net Assets Ratio
Hwail Pharmaceutical Co.Ltd (061250) has a Working Capital to Net Assets ratio of 59.3% as of September 2025. Working capital of ₩123.36 Billion (current assets of ₩128.37 Billion minus current liabilities of ₩5.01 Billion) is measured against net assets of ₩207.86 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can Hwail Pharmaceutical Co.Ltd fund operations to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Hwail Pharmaceutical Co.Ltd Working Capital to Net Assets (2013–2024)
This chart shows how Hwail Pharmaceutical Co.Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 59.3%, reflecting working capital of ₩123.36 Billion against net assets of ₩207.86 Billion KRW. For the complete balance sheet picture, see how large is Hwail Pharmaceutical Co.Ltd's balance sheet.
Annual Working Capital to Net Assets for Hwail Pharmaceutical Co.Ltd (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Hwail Pharmaceutical Co.Ltd from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Hwail Pharmaceutical Co.Ltd (061250) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 60.0% | ₩122.08 Billion | ₩203.42 Billion | ₩133.79 Billion | ₩11.71 Billion | ▼ -12.0 pp |
| 2023 | 72.0% | ₩125.60 Billion | ₩174.45 Billion | ₩136.63 Billion | ₩11.03 Billion | ▼ -2.1 pp |
| 2022 | 74.1% | ₩130.13 Billion | ₩175.57 Billion | ₩138.07 Billion | ₩7.94 Billion | ▼ -1.2 pp |
| 2021 | 75.3% | ₩136.76 Billion | ₩181.66 Billion | ₩148.83 Billion | ₩12.07 Billion | ▲ +15.3 pp |
| 2020 | 59.9% | ₩94.03 Billion | ₩156.86 Billion | ₩106.39 Billion | ₩12.36 Billion | ▼ -3.7 pp |
| 2019 | 63.6% | ₩76.01 Billion | ₩119.43 Billion | ₩95.77 Billion | ₩19.75 Billion | ▲ +5.9 pp |
| 2018 | 57.7% | ₩58.46 Billion | ₩101.25 Billion | ₩79.52 Billion | ₩21.06 Billion | ▼ -4.8 pp |
| 2017 | 62.6% | ₩61.42 Billion | ₩98.18 Billion | ₩79.11 Billion | ₩17.69 Billion | ▲ +5.5 pp |
| 2016 | 57.0% | ₩56.95 Billion | ₩99.86 Billion | ₩76.12 Billion | ₩19.17 Billion | ▲ +9.0 pp |
| 2015 | 48.0% | ₩47.53 Billion | ₩98.94 Billion | ₩81.02 Billion | ₩33.49 Billion | ▼ -10.6 pp |
| 2014 | 58.6% | ₩52.20 Billion | ₩89.07 Billion | ₩74.06 Billion | ₩21.86 Billion | ▲ +3.8 pp |
| 2013 | 54.8% | ₩47.31 Billion | ₩86.31 Billion | ₩72.70 Billion | ₩25.39 Billion | — |